A large community-based registry of patients treated with drug-eluting stents is providing important insight into how long patients with complex coronary artery disease typically stick to their doctors' orders to take clopidogrel, a drug that prevents unwanted blood clots; why they stop taking the drug; and the long-term consequences of that decision.
doctors ordersMatrix registry probes adherence to clopidogrel at 1 yearEurekAlert! - Medicine and Health Sun, 03/30/2008 - 23:00
|
